??-Retinoic Acid
Brand names,
??-Retinoic Acid
Analogs
??-Retinoic Acid
Brand Names Mixture
??-Retinoic Acid
Chemical_Formula
C20H28O2
??-Retinoic Acid
RX_link
http://www.rxlist.com/cgi/generic/tretinoin.htm
??-Retinoic Acid
fda sheet
??-Retinoic Acid
msds (material safety sheet)
??-Retinoic Acid
Synthesis Reference
Matsui et al.; J.Vitaminol.; 4; 190, 192(1958)
??-Retinoic Acid
Molecular Weight
300.435 g/mol
??-Retinoic Acid
Melting Point
181 oC
??-Retinoic Acid
H2O Solubility
<0.1 g/100 mL
??-Retinoic Acid
State
Solid
??-Retinoic Acid
LogP
5.067
??-Retinoic Acid
Dosage Forms
Capsule; Cream; Gel; Liquid
??-Retinoic Acid
Indication
For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.
??-Retinoic Acid
Pharmacology
Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).
??-Retinoic Acid
Absorption
1-31% (topical);
??-Retinoic Acid
side effects and Toxicity
No information avaliable
??-Retinoic Acid
Patient Information
No information avaliable
??-Retinoic Acid
Organisms Affected
Humans and other mammals